Literature DB >> 12691522

Modulation of splicing events in histone deacetylase 3 by various extracellular and signal transduction pathways.

S G Gray1, A H Iglesias, B T Teh, F Dangond.   

Abstract

Within the context of the chromatin environment histone deacetylases are important transcriptional regulators. Three classes of human histone deacetylases have currently been identified on the basis of their similarity to yeast proteins. The class I enzymes contain four members: HDACs 1-3 and HDAC8. Of these, HDAC3 is known to generate transcript variants with altered amino-terminal regions. Here we describe the identification of a novel splice variant of HDAC3, in which exon 3 is alternatively spliced from the messenger RNA transcript. We show that this human HDAC3 splice transcript is upregulated by treatments with histone deacetylase inhibitors. We also demonstrate evidence of splicing events in murine HDAC3 as a response to various signals, including switching between splice transcript isoforms following treatments with kinase inhibitors or by osmotic shock. In contrast, such switching events were not observed in human cells. These results indicate that differential pathways in mouse and human may control the regulation of HDAC3, and that splice variants may play important roles in responding to exogenous stimuli that act via signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691522      PMCID: PMC5991154          DOI: 10.3727/000000003783992342

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  33 in total

1.  Analysis of expressed sequence tags indicates 35,000 human genes.

Authors:  B Ewing; P Green
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

Review 2.  Alternative splicing: increasing diversity in the proteomic world.

Authors:  B R Graveley
Journal:  Trends Genet       Date:  2001-02       Impact factor: 11.639

3.  Cloning and characterization of a histone deacetylase, HDAC9.

Authors:  X Zhou; P A Marks; R A Rifkind; V M Richon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

4.  Induction of HSP-70 after hyperosmotic opening of the blood-brain barrier in the rat.

Authors:  J D Richmon; K Fukuda; F R Sharp; L J Noble
Journal:  Neurosci Lett       Date:  1995-12-29       Impact factor: 3.046

5.  Cloning and characterization of the murine histone deacetylase (HDAC3).

Authors:  U Mahlknecht; D Hoelzer; R Bucala; E Verdin
Journal:  Biochem Biophys Res Commun       Date:  1999-09-24       Impact factor: 3.575

6.  Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas.

Authors:  S G Gray; W Hartmann; T Eriksson; C Ekstrom; S Holm; S Kytola; D von Schweinitz; T Pietsch; C Larsson; P Kogner; B Sandstedt; T J Ekstrom
Journal:  Int J Mol Med       Date:  2000-08       Impact factor: 4.101

7.  Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain.

Authors:  Jenny J Tong; Jianhong Liu; Nicholas R Bertos; Xiang-Jiao Yang
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

8.  Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family.

Authors:  Lin Gao; Maria A Cueto; Fred Asselbergs; Peter Atadja
Journal:  J Biol Chem       Date:  2002-04-10       Impact factor: 5.157

9.  Novel splicing of an IGF2 polymorphic region in human adrenocortical carcinomas.

Authors:  S G Gray; M Kjellman; C Larsson; T J Ekström
Journal:  Biochem Biophys Res Commun       Date:  1997-10-29       Impact factor: 3.575

Review 10.  Alternative spliced transcripts as cancer markers.

Authors:  O L Caballero; S J de Souza; R R Brentani; A J Simpson
Journal:  Dis Markers       Date:  2001       Impact factor: 3.434

View more
  4 in total

1.  Cleavage and cytoplasmic relocalization of histone deacetylase 3 are important for apoptosis progression.

Authors:  Fabrice Escaffit; Olivier Vaute; Martine Chevillard-Briet; Bruno Segui; Yasunari Takami; Tatsuo Nakayama; Didier Trouche
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

2.  The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention.

Authors:  Gregory W Peek; Trygve O Tollefsbol
Journal:  Clin Epigenetics       Date:  2011-01-26       Impact factor: 6.551

Review 3.  Targeting histone deacetylases for the treatment of disease.

Authors:  M W Lawless; S Norris; K J O'Byrne; S G Gray
Journal:  J Cell Mol Med       Date:  2008-11-03       Impact factor: 5.310

4.  The Selective Histone Deacetylase Inhibitor MI192 Enhances the Osteogenic Differentiation Efficacy of Human Dental Pulp Stromal Cells.

Authors:  Kenny Man; Liam Lawlor; Lin-Hua Jiang; Xuebin B Yang
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.